Literature DB >> 26843246

A novel perfused Bloch-McConnell simulator for analyzing the accuracy of dynamic hyperpolarized MRS.

Christopher M Walker1, Yunyun Chen2, Stephen Y Lai2, James A Bankson1.   

Abstract

PURPOSE: Magnetic resonance spectroscopy of hyperpolarized agents allows real-time detection of metabolism in vivo. However, the nonrenewable nature of these signals necessitates data acquisitions that differ significantly from conventional magnetic resonance imaging. Signal evolution is permanently altered by the data acquisition scheme, potentially leading to sequence parameter-dependent bias in quantification. The authors have developed a novel simulation environment to characterize the effects of sequence parameters on magnetic resonance spectroscopy-based chemical exchange measurements using hyperpolarized pyruvate.
METHODS: Conventional Bloch-McConnell equations were coupled with a pharmacokinetic model for perfusion to allow realistic simulation of in vivo dynamic hyperpolarized signal evolution. In this study, simulations were conducted to explore effects of excitation angle and repetition time on the observed signal and subsequent parametric analysis. Both high and low apparent exchange rates were modeled under assumption of both perfused and closed systems. Bias due to sampling strategy bias was subsequently tested in vivo.
RESULTS: Simulation of dynamic magnetic resonance spectroscopy studies using hyperpolarized pyruvate demonstrated that for closed systems, accurate measurement of the apparent exchange rate was possible over a wide range of sequence parameters. This was true for both high and low apparent exchange rates, although a low exchange rate was associated with larger errors when excitation angles were high. When effects of perfusion were included to account for pyruvate delivery, a more restricted range of settings led to accurate quantification of exchange rates. Perfusion alleviated some of the errors seen at high excitation angles for low exchange rates. Residuals from parametric analysis did not generally correlate with fit accuracy, implying that the quality of the analysis model was not a major driver of error. Animal studies acquired with sequence parameters that are predicted to impart bias showed a significant under estimation of exchange rates (P < 0.035) compared to parameter combinations that are not expected to bias measurements.
CONCLUSIONS: The authors' results suggest that great care must be taken when measuring dynamic processes by magnetic resonance spectroscopy of hyperpolarized substrates. When comparing apparent exchange rates, choice of sequence parameters will affect the results. Bias introduced by parameters of more advanced acquisition and reconstruction schemes will likely increase compared to the relatively simple dynamic spectroscopy methods tested herein. The modified Bloch-McConnell equations the authors describe will be crucial tools for characterizing and optimizing the performance of these more advanced techniques.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26843246      PMCID: PMC4723412          DOI: 10.1118/1.4939877

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  35 in total

1.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

2.  Non-invasive in vivo assessment of IDH1 mutational status in glioma.

Authors:  Myriam M Chaumeil; Peder E Z Larson; Hikari A I Yoshihara; Olivia M Danforth; Daniel B Vigneron; Sarah J Nelson; Russell O Pieper; Joanna J Phillips; Sabrina M Ronen
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 3.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

4.  Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice.

Authors:  Matthew L Zierhut; Yi-Fen Yen; Albert P Chen; Robert Bok; Mark J Albers; Vickie Zhang; Jim Tropp; Ilwoo Park; Daniel B Vigneron; John Kurhanewicz; Ralph E Hurd; Sarah J Nelson
Journal:  J Magn Reson       Date:  2009-10-13       Impact factor: 2.229

5.  Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma.

Authors:  James W Fletcher; Theodore F Logan; Jacob A Eitel; Carla J Mathias; Yen Ng; Jeffrey L Lacy; Gary D Hutchins; Mark A Green
Journal:  J Nucl Med       Date:  2014-12-18       Impact factor: 10.057

6.  Comparison of kinetic models for analysis of pyruvate-to-lactate exchange by hyperpolarized 13 C NMR.

Authors:  Crystal Harrison; Chendong Yang; Ashish Jindal; Ralph J DeBerardinis; M A Hooshyar; Matthew Merritt; A Dean Sherry; Craig R Malloy
Journal:  NMR Biomed       Date:  2012-03-26       Impact factor: 4.044

7.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy.

Authors:  Sam E Day; Mikko I Kettunen; Ferdia A Gallagher; De-En Hu; Mathilde Lerche; Jan Wolber; Klaes Golman; Jan Henrik Ardenkjaer-Larsen; Kevin M Brindle
Journal:  Nat Med       Date:  2007-10-28       Impact factor: 53.440

8.  Optimal variable flip angle schemes for dynamic acquisition of exchanging hyperpolarized substrates.

Authors:  Yan Xing; Galen D Reed; John M Pauly; Adam B Kerr; Peder E Z Larson
Journal:  J Magn Reson       Date:  2013-06-14       Impact factor: 2.229

Review 9.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

10.  Kinetic modeling of hyperpolarized (13)C pyruvate metabolism in tumors using a measured arterial input function.

Authors:  S M Kazan; S Reynolds; A Kennerley; E Wholey; J E Bluff; J Berwick; V J Cunningham; M N Paley; G M Tozer
Journal:  Magn Reson Med       Date:  2012-11-20       Impact factor: 4.668

View more
  6 in total

1.  Influence of parameter accuracy on pharmacokinetic analysis of hyperpolarized pyruvate.

Authors:  Chang-Yu Sun; Christopher M Walker; Keith A Michel; Aradhana M Venkatesan; Stephen Y Lai; James A Bankson
Journal:  Magn Reson Med       Date:  2017-11-01       Impact factor: 4.668

2.  Effects of excitation angle strategy on quantitative analysis of hyperpolarized pyruvate.

Authors:  Christopher M Walker; David Fuentes; Peder E Z Larson; Vikas Kundra; Daniel B Vigneron; James A Bankson
Journal:  Magn Reson Med       Date:  2019-02-22       Impact factor: 4.668

3.  Summary of Imaging in 2020: Visualizing the Future of Healthcare with MR Imaging.

Authors:  Brooke A Corbin; Alyssa C Pollard; Matthew J Allen; Mark D Pagel
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

4.  Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients.

Authors:  Jeremy W Gordon; Hsin-Yu Chen; Adam Autry; Ilwoo Park; Mark Van Criekinge; Daniele Mammoli; Eugene Milshteyn; Robert Bok; Duan Xu; Yan Li; Rahul Aggarwal; Susan Chang; James B Slater; Marcus Ferrone; Sarah Nelson; John Kurhanewicz; Peder E Z Larson; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2018-10-30       Impact factor: 4.668

Review 5.  Virtual clinical trials in medical imaging: a review.

Authors:  Ehsan Abadi; William P Segars; Benjamin M W Tsui; Paul E Kinahan; Nick Bottenus; Alejandro F Frangi; Andrew Maidment; Joseph Lo; Ehsan Samei
Journal:  J Med Imaging (Bellingham)       Date:  2020-04-11

6.  The effect of transmit B1 inhomogeneity on hyperpolarized [1-13 C]-pyruvate metabolic MR imaging biomarkers.

Authors:  Collin J Harlan; Zhan Xu; Christopher M Walker; Keith A Michel; Galen D Reed; James A Bankson
Journal:  Med Phys       Date:  2021-08-10       Impact factor: 4.506

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.